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Salmonella  Typhimurium  is  major  cause  of invasive  nontyphoidal  Salmonella  disease  in  Africa.  Conjuga-
tion  of S. Typhimurium  O-antigen  to  an  appropriate  carrier  protein  constitutes  a  possible  strategy  for  the
development  of a  vaccine  against  this  disease,  for which  no  vaccines  are  currently  available.  The  con-
jugation  chemistry  used  is one  of  the parameters  that  can affect  the  immunogenicity  of glycoconjugate
vaccines.  Herein  different  glycoconjugates  were  synthesized  to investigate  the  impact  of  this  variable
on  the  immunogenicity  of  S. Typhimurium  conjugate  vaccines  in  mice,  all with  CRM197 as  carrier  pro-
tein.  Random  derivatization  along  the  O-antigen  chain  was  compared  with  site-directed  activation  of  the
terminal  KDO  sugar  residue  of  the core  oligosaccharide.  In particular,  two  different  random  approaches
were  used,  based  on  the  oxidation  of  the polysaccharide,  which  differently  impact  the  structure  and  con-
formation  of  the  O-antigen  chain.  For  the  selective  conjugation  methods,  linkers  of  two  different  lengths
were  compared.
When  tested  in  mice,  all conjugates  induced  anti-O-antigen  IgG  antibodies  with  serum  bactericidal
activity.  Similar  anti-O-antigen  antibody  levels  were  elicited  independent  of  the chemistry  used  and  a
higher  degree  of  saccharide  derivatization  did  not  impact  negatively  on the  anti-O-antigen  IgG response.
Bactericidal  activity  of  serum  antibodies  induced  by selective  conjugates  was similar  independent  of
the  length  of  the  spacer  used.  Random  conjugates  elicited  antibodies  with  greater  bactericidal  activity
than  selective  ones,  and  an inverse  correlation  was  found  between  degree  of  O-antigen  modiﬁcation  and
antibody  functional  activity.
© 2014  The  Authors.  Published  by Elsevier  Ltd. This  is  an open  access  article  under  the  CC  BY-NC-SA. Introduction
In many parts of Africa, nontyphoidal Salmonellae (NTS) are
he leading cause of bacteremia. Incidence of disease caused
y different serovars varies depending upon the country, but S.
yphimurium is the overall major cause of invasive NTS (iNTS) dis-
ase [1,2]. iNTS disease was recently estimated at 2.58 million cases
er year with a 20% case-fatality rate leading to 517,000 deaths [3].
oung children [4,5], children with HIV infection [6], malaria [7],
nemia and malnutrition [8], and HIV infected adults [9,10] are par-
icularly affected. Antibiotics are widely used to treat iNTS disease,
ut the increasing frequency of multidrug-resistant clinical iso-
ates is concerning and hampers the effectiveness of this treatment
n man  [11]. Until improved sanitary conditions and widespread
rovision of clean drinking water can be guaranteed, vaccination
onstitutes the most promising strategy for the control of iNTS
∗ Corresponding author. Tel.: +39 0577 539087; fax: +39 0577 243540.
E-mail address: francesca.micoli@novartis.com (F. Micoli).
ttp://dx.doi.org/10.1016/j.vaccine.2014.08.056
264-410X/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article unlicense  (http://creativecommons.org/licenses/by-nc-sa/3.0/).
disease in developing countries. No vaccines are currently available
to prevent iNTS disease in man.
Surface polysaccharides from bacteria have been used for many
years in vaccine applications, being both essential virulence fac-
tors and targets for protective antibodies. Covalent conjugation to
an appropriate carrier protein is an important mean of increasing
the immunogenicity of polysaccharides [12–15]. Glycoconjugate
vaccines elicit T cell-dependent immunogenicity against the sac-
charide. With the involvement of T cells, immunological memory
is induced, and afﬁnity maturation and isotype switching from IgM
to IgG occur. Unlike pure polysaccharides, glycoconjugate vaccines
are effective in young infants.
Antibodies directed against the O-antigen (OAg) of NTS mediate
killing [16–18] and confer protection against infection in animal
models [19,20]. Therefore, OAg glycoconjugates have been pro-
posed as a vaccine strategy against Salmonella for use in man  [21].The synthesis of glycoconjugate vaccines requires a covalent
linkage between the saccharide and the carrier protein. Many con-
jugation methods have been proposed, all following two main
approaches: random chemical activation along the polysaccharide
der the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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hain, followed by conjugation to the carrier protein, and coupling
o the protein through selective activation of the terminal reducing
nit of the saccharide chain [14,15,22,23]. The choice of conjuga-
ion strategy can affect the efﬁciency of conjugation, saccharide to
rotein ratio and glycoconjugate structure and size, with conse-
uent impact on immunogenicity [15]. Spacer molecules are often
ntroduced between the saccharide and protein to reduce steric
indrance and facilitate conjugation.
Here we investigate different conjugation strategies for linking
. Typhimurium OAg to CRM197 [23] and compare the impact of
hese chemistries on the immunogenicity of the resulting conju-
ates in mice.
. Materials and methods
SI Materials and Methods feature additional information.
.1. OAg puriﬁcation and characterization
S. Typhimurium OAg was puriﬁed as previously described
24], following fermentation of the animal-derived isolate, 2192,
btained from the University of Calgary, or of the laboratory strain
T2, obtained from the Novartis Master Culture Collection. OAg
reparations were characterized by protein content <1% (by micro
CA), nucleic acid content <0.5% (by A260) and endotoxin level
0.1 UI/g  (by LAL). Full characterization of the OAg chains from
hese two strains have been previously reported [25]. In partic-
lar, 2192 OAg, used for the synthesis of the conjugates tested in
ice, was 24% glucosylated and 100% O-acetylated on C-2 abequose
Abe). It showed an average molecular weight (MW)  distribution
f 20.5 kDa, determined from the molar ratio of rhamnose (Rha;
ugar of the OAg chain) to N-acetyl glucosamine (GlcNAc; core
ugar), sugar composition analysis by HPAEC-PAD and consider-
ng the level of O-acetylation by NMR  analysis. OAg chains showed
he presence of NH2 groups (NH2 to GlcNAc molar ratio % of 37.6),
s detected by TNBS colorimetric method [26,27], probably as
yrophosphoethanolamine residues in the core region (Fig. S1).
.2. Synthesis of OAg-CRM197 glycoconjugates
OAg-oxNaIO4-CRM197: random activation of the OAg chain with
aIO4 and conjugation to CRM197. OAg (10 mg/mL  in AcONa
00 mM pH 5) was stirred for 2 h in the dark with 3.75 mM
aIO4. The mixture was desalted using a HiPrepTM 26/10 desalt-
ng column 53 mL,  prepacked with SephadexTM G-25 Superﬁne
GE Healthcare], and the pool, eluted at the void volume of
he column, was dried. The activated OAg was  designated OAg-
xNaIO4. For conjugation to CRM197, OAg-oxNaIO4 was added to
RM197 in NaH2PO4 100 mM pH 7.2 to give a ﬁnal concentration
f 10 and 5 mg/mL, respectively. NaBH3CN was added immedi-
tely after (OAg-oxNaIO4:NaBH3CN = 1:1 w/w), and the reaction
ixture stirred overnight at 37 ◦C. After this time, NaBH4 (OAg-
xNaIO4:NaBH4 = 1:1 w/w) was added and the mixture was  stirred
t 37 ◦C for 2 h. The conjugate was designated OAg-oxNaIO4-
RM197.
OAg-oxTEMPO-CRM197: random activation of the OAg chain
ith TEMPO and conjugation to CRM197. OAg (3 mg/mL, corre-
ponding to [CH2OH] of 7.69 mM)  and NaHCO3 (molar ratio
aHCO3/CH2OH = 30), were added to a stirred solution of TEMPO
molar ratio TEMPO/CH2OH = 0.05) in DMF. The reaction was  cooled
o 0 ◦C and TCC (molar ratio TCC/CH2OH = 1.6) was added. The
ctivated sugar was recovered from the reaction mixture by precip-
tation with EtOH (85 v/v% in the ﬁnal mixture) after 2 h of stirring
t 0 ◦C. The pellet was washed twice with 100% EtOH (1.5 volumes
ith respect to the reaction mixture volume) and lyophilized. The2 (2014) 6122–6129 6123
activated OAg was designated OAg-oxTEMPO2h. The same proce-
dure was  used for the synthesis of OAg-oxTEMPO12h, increasing
the reaction time to 12 h. OAg-oxTEMPO2 h and OAg-oxTEMPO12h
were conjugated to CRM197, using the same conditions for OAg-
oxNaIO4. The two corresponding conjugates were designated
OAg-oxTEMPO2h-CRM197 and OAg-oxTEMPO12h-CRM197, respec-
tively.
OAg-ADH-SIDEA-CRM197: selective activation of the terminal KDO
with ADH, followed by reaction with SIDEA and conjugation to
CRM197. The synthesis of this conjugate was performed as previ-
ously described [28] and detailed in SI.
OAg-NH2-SIDEA-CRM197: selective activation of the terminal KDO
with NH4OAc, followed by reaction with SIDEA and conjugation
to CRM197. OAg was solubilized in 500 mM NH4OAc pH 7.0 at
a concentration of 40 mg/mL. NaBH3CN was added immediately
(NaBH3CN:OAg = 2:5 w/w).  The solution was mixed at 30 ◦C for 5
days. The reaction mixture was desalted on a G-25 column and the
OAg-NH2 was dried. The following steps of conjugation were per-
formed as for OAg-ADH-SIDEA-CRM197 and the resulting conjugate
was designed OAg-NH2-SIDEA-CRM197.
All conjugates were puriﬁed by hydrophobic interaction chro-
matography (HIC) on a Phenyl HP column [GE Healthcare], loading
500 g of protein for mL  of resin in 50 mM NaH2PO4 3 M NaCl pH
7.2. The puriﬁed conjugate was eluted in water and the collected
fractions were dialyzed against 10 mM NaH2PO4 pH 7.2.
2.3. Conjugates characterization
Total saccharide was  quantiﬁed by phenol sulfuric assay [29],
protein content by micro BCA (using BSA as standard and following
manufacturer’s instructions [Thermo Scientiﬁcs]) and the ratio of
saccharide to protein calculated. OAg-CRM197 conjugates proﬁles
were compared with free CRM197 by HPLC-SEC and SDS-PAGE (see
SI).
Methods used for the characterization of derivatized OAg inter-
mediates are described in SI.
2.4. Immunogenicity study in mice and serological analysis
Seven groups of eight 5-week old female C57BL/6 mice were
purchased from Charles River Laboratory and maintained at
Novartis Vaccines Animal Care. Mice received three subcutaneous
immunizations at 14 days-interval with 200 L/dose of 1 g of con-
jugated OAg. Mice were bled before the ﬁrst immunization (day
0) and two  weeks after each immunization. All animal protocols
were approved by the local animal ethical committee (approval N.
AEC201018) and by the Italian Minister of Health in accordance
with Italian law.
Serum IgG, IgM and IgA levels against both OAg  and CRM197
were measured by ELISA (see SI) [28,30]; day 42 sera were
additionally assessed for serum bactericidal activity (SBA) and
binding capacity (ﬂow cytometry) of two  invasive clinical isolates
(see SI). Statistical analysis of ELISA results was conducted using
Kruskal–Wallis test, with Dunn’s post hoc analysis (  ˛ = 0.05).
3. Results
3.1. OAg oxidation with NaIO4 and reductive amination with
CRM197
NaIO4-based oxidation affects vicinal diols to generate two alde-
hyde groups, opening the sugar ring. In the case of S. Typhimurium
OAg, this reactivity can involve Rha and glucose (Glc) residues
(Fig. 1a). The resulting aldehyde groups can then react with the
amine group on lysine residues of the carrier protein to form a
covalent C N linkage, which is subsequently reduced to a stable
6124 G. Stefanetti et al. / Vaccine 32 (2014) 6122–6129
Fig. 1. (a) Structure of S. Typhimurium OAg chain and random derivatization by NaIO4 and TEMPO oxidation. For 2192 OAg, repeating units number (n) = 28, as calculated
from  the molar ratio of Rha to GlcNAc by HPAEC-PAD analysis. The NaIO4-based oxidation affects vicinal diols generating two  aldehyde groups and opening the sugar ring.
For  S. Typhimurium OAg, this can involve Rha and Glc residues. TEMPO oxidation targets primary alcohol groups, which in S. Typhimurium OAg are present in the sugar
moieties of Man, Gal and Glc, with one per monosaccharide. In both cases, the resulting aldehyde groups can then react with the lysine residues of the carrier protein to form
a  covalent C N linkage, which is subsequently reduced to a stable C N bond with NaBH3CN. A further step of reduction with NaBH4 was  introduced to quench unreacted
C  O groups. (b) OAg selective derivatization of the reducing end unit KDO on the core oligosaccharide. Reductive amination of KDO with NH4OAc or ADH, followed by SIDEA
addition and conjugation to CRM197. The two chemistries differ for the spacer length.
G. Stefanetti et al. / Vaccine 32 (2014) 6122–6129 6125
Fig. 2. HPLC-SEC proﬁles of (a) underivatized 2192 OAg (average MW of 20.5 kDa) in comparison with (b) OAg-oxNaIO4 and (c) OAg-oxTEMPO12h. TSKgel 3000 PWXL,
0.5  mL/min, 100 mM NaCl 100 mM NaH2PO4 5% CH3CN pH 7.2; Vtot 23.29 min; V0 11.20 min; RI detection.
Fig. 3. HPLC-SEC (ﬂuorescence emission proﬁles) of (a) free CRM197; (b) random conjugates: OAg-oxTEMPO2h-CRM197 (dotted line), OAg-oxTEMPO12h-CRM197 (dashed
line)  and OAg-oxNaIO4-CRM197 (solid line); (c) selective conjugates: OAg-ADH-SIDEA-CRM197 (dotted line) and OAg-NH2-SIDEA-CRM197 (solid line). TSKgel 6000 PW + 5000
PW,  0.5 mL/min, 100 mM NaCl 100 mM NaH2PO4 5% CH3CN pH 7.2; Vtot 49.004 min; V0 24.382 min.
6 ccine 32 (2014) 6122–6129
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 N bond with NaBH3CN. A further reduction step with NaBH4
as introduced to quench unreacted C O groups (see SI).
The reaction conditions applied to 2192 OAg were derived from
n optimization performed with the LT2 S. Typhimurium labora-
ory strain (see SI). The HPLC-SEC proﬁle of the oxidized OAg in
omparison with the underivatized OAg (average MW of 20.5 kDa)
howed a shift of the main peak to a slightly lower MW (Fig. 2a
nd b). By micro BCA, 14% of OAg repeating units were found to be
erivatized (calculated as number of oxidized monomers/total OAg
epeating units × 100). HPAEC-PAD analysis showed that 14% of the
ha and 6.4% of the Glc residues were oxidized, with 15.5% of total
epeating units modiﬁed. All CRM197 in the conjugation mixture
ecame linked to OAg, while 36% of OAg was conjugated. HPLC-
EC analysis demonstrated a shift for the conjugate to a higher
W compared with free protein (Fig. 3b and a) and was  used for
stimating conjugate MW distribution (Table 1).
.2. OAg oxidation with TEMPO and reductive amination with
RM197
Oxidation of 2192 OAg with TEMPO allowed random formation
f aldehyde groups along the chain without opening the sugar rings,
s oxidation with NaIO4 does. TEMPO oxidation targets primary
lcohol groups. These are present in Man, Gal and Glc residues of
. Typhimurium OAg, with one per monosaccharide. The resulting
ldehyde groups can then react with the lysine residues on the car-
ier protein by reductive amination as for derivatization with NaIO4
Fig. 1a).
Oxidation of 2192 OAg with TEMPO was followed over time and
he % of OAg monomers oxidized increased from 15% after 2 h to 36%
fter 12 h, as detected by micro BCA. HPLC-SEC analysis showed that
Ag MW distribution remained unchanged after oxidation, even
hen the reaction was performed for longer times (Fig. 2c and a),
n contrast to what was obtained with NaIO4 (Fig. 2b).
OAg-oxTEMPO with an average percentage number of oxidized
epeating units of 36% and 15% were conjugated to CRM197, to
nvestigate the impact of the degree of OAg derivatization on the
mmunogenicity of the corresponding conjugates.
The same conditions for the conjugation and puriﬁcation of OAg-
xNaIO4 were applied and in both cases all CRM197 in the reaction
ixtures was conjugated, with 19–28% of OAg conjugated (Fig. 3b).
onjugates obtained using less derivatized OAg (both after treat-
ent with NaIO4 or TEMPO) were characterized by a higher OAg
o protein ratio with respect to the conjugate obtained from more
xidized OAg which was able to couple to more CRM197 molecules
Table 1).
.3. Selective conjugation chemistries
The terminal KDO residue of the core oligosaccharide was used
or selective linking of OAg to CRM197 without modifying the OAg
hain. To generate one conjugate vaccine, reductive amination with
DH was followed by reaction with SIDEA and conjugation to
RM197 [28]. A similar chemistry was evaluated where the ﬁrst
tep of reductive amination was conducted with NH4OAc, allow-
ng the synthesis of a conjugate with a linker about half the length
f ADH-SIDEA (Fig. 1b).
After testing the reactivity of OAg-KDO with NH4OAc under dif-
erent conditions (see SI), in order to synthesize the corresponding
onjugate, the reaction was performed at pH 7.0 for 5 days resulting
n the activation of 90% of OAg chains. Use of the longer ADH linker
ith the hydrazide functionality allowed the reaction to proceed,
ith activation close to 100% after only 2 h at pH 4.5. In the follow-
ng step where the OAg derivatives were reacted with SIDEA, >90%
f total NH2 groups were coupled to SIDEA, for both OAg-NH2 and
Ag-ADH. The analysis of the corresponding conjugation mixturesFig. 4. (a) Anti-OAg IgG ELISA units against 2192 OAg coating agent. (b) Anti-CRM197
IgG ELISA units against CRM197 coating agent. Individual animals are represented by
the dots; horizontal bars represent Geometric Mean Units.
by HPLC-SEC, conﬁrmed conjugate formation without residual free
protein, while the amount of conjugated OAg was close to 15% in
both cases. The resulting conjugates were very similar in terms
of OAg to CRM197 ratio (4–5 OAg chains linked per protein) and
molecular size, measured as distribution coefﬁcient Kd by HPLC-
SEC; even if OAg-NH2-SIDEA-CRM197 showed a slightly broader
population (Table 1, Fig. 3c). Selective conjugates contained higher
OAg to protein ratios than random conjugates (Table 1).
3.4. Immunogenicity study in mice of OAg-CRM197 comparing
different conjugation chemistries
The synthesized conjugates were tested in mice, with the fol-
lowing main objectives: to compare the immunogenicity of random
versus selective conjugates; to analyze the impact of linker chain
length on the immunogenicity of selective conjugates; to evalu-
ate whether the degree of random modiﬁcation of the OAg chain
impacts on immunogenicity.
After three doses, all the conjugates generated anti-OAg IgG
levels that were not statistically different (Fig. 4a). Antibody sub-
class analysis showed that IgG1 was  the predominant subclass for
all conjugates and no IgA was detected in any serum (Fig. S2).
Anti-OAg IgM were detected only at day 42 for OAg-oxTEMPO
conjugates (Fig. S3). After two  doses, anti-CRM197 IgG responses
obtained with OAg-oxTEMPO-CRM197 conjugates were higher than
for the other groups, likely the result of the higher proportion
of carrier protein present in these vaccines compared with the
G. Stefanetti et al. / Vaccine 32 (2014) 6122–6129 6127
Table  1
OAg-CRM197 conjugates generated using different chemistry.
Conjugate % Repeating units
oxidized*
OAg/CRM197 (w/w)  in
puriﬁed conjugate
OAg/CRM197 (mol/mol)
in puriﬁed conjugate
Kd puriﬁed conjugate
(HPLC-SEC)
Peak width (min) at
half length (HPLC-SEC)
OAg-oxNaIO4-CRM197 14 0.72 2.05 0.57 4.96
OAg-oxTEMPO2h-CRM197 15 0.56 1.6 0.44 7.59
OAg-oxTEMPO12h-CRM197 36 0.38 1.08 0.50 6.67
OAg-NH2-SIDEA-CRM197 na 1.42 4.05 0.50 5.75
OAg-ADH-SIDEA-CRM197 na 1.74 4.96 0.49 4.75
K l 100
0
o
b
C
S
[
k
(
s
o
w
t
c
o
C
a
s
i
a
f
F
od values were calculated on a TSKgel 6000 PW + 5000 PW,  0.5 mL/min, 100 mM NaC
.72;  Kd of free 2192 OAg: 0.67. na: not applicable.
* % repeating units oxidized calculated by micro BCA.
thers (Table 1). After three doses, differences were signiﬁcant only
etween OAg-oxTEMPO2h-CRM197, and both OAg-NH2-SIDEA-
RM197 and OAg-ADH-SIDEA-CRM197 (p = 0.0025) (Fig. 4b).
Sera collected at day 42 were pooled and tested for SBA against
. Typhimurium D23580, an invasive Malawian clinical isolate
31]. All conjugates induced bactericidal antibodies with complete
illing achieved with as little as 0.1 anti-OAg IgG ELISA units/mL
Fig. 5a). Bactericidal activity of sera from mice immunized with
elective OAg-KDO conjugates was similar, regardless of the length
f the spacer used, while all the random conjugates induced sera
ith greater bacterial growth inhibition per anti-OAg IgG ELISA unit
han the selective conjugates. There was a trend for less bacteri-
idal activity with increasing degree of OAg chain derivatization
f the random conjugates: the least derivatized OAg-oxTEMPO2h-
RM197 conjugate produced sera with the highest bactericidal
ctivity.
To evaluate possible differences in cell-surface binding, pooled
era at day 42 were tested by FACS against two S. Typhimurium
nvasive clinical isolates D23580 and Ke238. As shown in Fig. 5b,
ll sera could bind both strains, and greater antibody binding was
ound with random conjugates-sera.
ig. 5. (a) SBA analysis of pooled sera at day 42: CFU/mL of S. Typhimurium D23580 strain 
f  S. Typhimurium Ke238 and D23580. Bacteria were stained with day 42 pooled mice se mM NaH2PO4 5% CH3CN pH 7.2; Vtot 49.004 min; V0 24.382 min; Kd  of free CRM197:
4. Discussion
There is increasing awareness of the signiﬁcance of NTS as a
major public health concern in the developing world [1,32,33].
While responsible for gastroenteritis in high-income countries, NTS
is a common cause of fatal invasive disease in Africa. Currently no
vaccines are available against this disease and glycoconjugation is
a promising approach for vaccine development [34].
The conjugation chemistry used to synthesize a glycoconju-
gate vaccine can impact on its immunogenicity [15]. Here S.
Typhimurium OAg-CRM197 conjugates obtained by random deriva-
tization along the sugar chain were compared with conjugates
obtained by one-site linkage at the terminus of the core region.
For the random approach, a milder oxidation by TEMPO was com-
pared to oxidation with NaIO4 which opens the sugar units with
corresponding likely greater impact on OAg epitopes and confor-
mation. Regarding the selective approach, two different lengths of
the spacer present between the sugar and the protein were com-
pared.
From a process perspective, all conjugation methods resulted in
no residual free protein, which is the most expensive component
against anti-OAg IgG ELISA units/mL. (b) Flow cytometry analysis of surface staining
ra raised against the different conjugates.
6 ccine 3
o
t
r
s
O
a
u
c
r
g
d
t
c
c
d
c
t
a
d
o
i
r
d
r
s
o
v
j
g
s
g
G
s
i
c
c
o
c
[
t
i
t
t
i
p
i
c
v
c
t
A
t
A
f
2
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[128 G. Stefanetti et al. / Va
f the vaccine. The carrier protein did not need to be deriva-
ized for both type of chemistries, but the production of
andom conjugates required one step less compared with the
elective ones. Moreover, random approaches resulted in higher
Ag conjugation yields (about twice as much as with selective
pproach) with advantages in terms of total vaccine costs. However,
se of selective chemistry can add beneﬁts in terms of production
onsistency [35–37].
Selective and random conjugates induced a similar anti-OAg IgG
esponse and no differences were found between selective conju-
ates synthesized with different linker lengths. Anti-OAg IgM were
etected only in mice immunized with TEMPO conjugates after
hree doses.
Random conjugates induced antibodies with greater bacteri-
idal activity per anti-OAg IgG ELISA unit compared with selective
onjugates, conﬁrming that the modiﬁcation along the sugar chain
id not negatively affect conjugate immunogenicity, even though it
ould impact on OAg epitope integrity and conformation. However,
here was an inverse correlation between degree of derivatization
nd bactericidal activity of the antibodies induced among the ran-
om conjugates. FACS analysis conﬁrmed that the higher degree
f random derivatization did not negatively impact on the abil-
ty of the corresponding conjugates to induce antibodies able to
ecognize the two invasive S. Typhimurium strains tested.
The difference in the bactericidal activity could be related to the
ifferent OAg to protein ratio of the various conjugates (lower for
andom ones), or to the different structures of the conjugates them-
elves: a sun-structure for the selective conjugates with no points
f direct linkage between the OAg polysaccharide and the protein,
ersus a cross-linked heterogeneous structure of the random con-
ugates. This second conﬁguration may  lead to more CRM197-OAg
lycopeptides after processing in the B-cells. According to a recent
tudy, T cell populations can recognize carbohydrate epitopes on
lycopeptides derived from antigen-presenting cell processing of
roup B Streptococcus conjugate vaccines and high-density pre-
entation of carbohydrate epitopes could have an important role
n determining the success of a conjugate vaccine [38]. Different
hemistries could also impact on the presentation of the sugar and
arrier epitopes to the immune system. Furthermore, the presence
f the linker in the selective but not in the random conjugates
ould be an additional factor affecting antibody functional activity
28,39].
In the context of NTS OAg-based glycoconjugate vaccines,
here are only a few studies that have investigated to date the
nﬂuence of conjugation chemistry on immunogenicity, and con-
rasting ﬁndings have been obtained [19,20,28]. This emphasizes
he complexity of the immune response to glycoconjugates which
s inﬂuenced by different strongly-interconnected conjugation
arameters [15].
This study highlights the importance of conjugation chemistry
n the design of S. Typhimurium OAg-based glycoconjugate vac-
ines. A better knowledge of the ﬁne structure of such candidate
accines, together with the design and testing of other well-deﬁned
onjugate vaccines, would contribute to further understanding of
he relationship between conjugate structure and immunogenicity.
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